Rocket Pharmaceuticals is acquiring Renovacor, a gene therapies developer whose lead program addresses a particular genetic mutation that leads to a type of heart failure. The all-stock deal gives Rocket the opportunity to expand its reach in genetically driven cardiac diseases.
September 28, 2022 at Pegasus Park in Dallas is your opportunity to network with over 30 investors (a 6:1 ratio), meet select Employee Benefits Startups, and participate in expert panel discussions around mental health, pharmacy benefits, the cost of healthcare, reaching consumers and the future of digital health.
By Stephanie Baum Wednesday, September 21, 2022 7:30 AM
In an interview, HLTH's Head of Content Jody Tropeano shares how the annual conference has adopted a festival-like vibe with an innovative layout to maximize interaction, with content highlighting topics such as women's health, wellness, and employer health.
By Brent Dover Wednesday, September 21, 2022 1:06 AM
Legislative solutions to expand healthcare pricing transparency have fallen short, but that doesn't mean we're out of options. Emphasizing technological fixes and collaborative solutions show promise for a complex problem.
By Marissa Plescia Tuesday, September 20, 2022 5:42 PM
The funding round was led by American Family Ventures and brings the company's total funds to $20 million. With the money, TCARE will grow its team and work to expand its offerings for its existing clients.
By Frank Vinluan Tuesday, September 20, 2022 5:13 PM
A Merck HIV drug placed under multiple full and partial clinical holds last year is now clear to resume testing. As part of a modified plan, Merck will test a lower dose of its experimental drug, islatravir. The pharma giant is also dropping tests of the drug for HIV prevention.
By Marissa Plescia Tuesday, September 20, 2022 4:54 PM
Over 1 million Medicare beneficiaries had a diagnosis for opioid use disorder in 2021. But despite this high number, only 18% received medication to treat their disorder.
No comments